Celebrity involvement, injury rumors, NXT call-ups and main event scenarios — here’s the latest on WrestleMania 42 heading into the go-home SmackDown.
Formation Bio CEO Ben Liu is convinced that drug discovery isn’t the bottleneck in getting medicines to market—it’s going through clinical trials. Now he’s raised some $615 million from top investors to buy stalled drugs and use AI to stress test them …
The Swedish telecoms equipment maker narrowly missed profit forecasts, with adjusted EBITA falling 20% year-on-year to SEK 5.6 billion. North America, which drove a 20%+ surge in Q1 2025, declined sharply as prior-year pull-forward investment unwinds. …
AI makers are starting to allow ads to during AI chats. Good or bad? Time will tell. Lawyers and law firms are aiming to place such ads. Good or bad? An AI Insider scoop.
The Pitt’s season 2 finale lands a lot of the emotional beats, but never quite lives up to Season 1’s masterful ending.
Looking for help with today’s New York Times Wordle? Here are some expert hints, clues and commentary to help you solve today’s Wordle and sharpen your guessing game.
Looking for help with today’s New York Times Pips? We’ll walk you through today’s puzzle and help you match dominoes to tiles.
Does Invincible Season 4, Episode 7 have a power balancing problem? We break down the latest episode’s combat logic and the one major issue holding the series back.
Chinese fantasy novels reimagine the past with modern tech and ideology. A new book argues they also help reinforce authoritarian politics.
In Musk v. Altman, a jury will soon determine whether OpenAI has strayed from its founding mission to ensure AGI benefits humanity. Here’s what to know.